Table 3.
SOD and MDA contents in liver tissue and serum levels of AST, ALT, and ALP in PCOS and non-PCOS rats
|
| |||||
|---|---|---|---|---|---|
| Group | SOD (U/ml) | MDA (µL) | AST (U/L) | ALT (U/L) | ALP (U/L) |
|
| |||||
| Control | 0.49 ± 0.034 | 3.46 ± 0.075 | 149.50 ± 5.14 | 143.00 ± 5.80 | 971.7 ± 40.45 |
| PCOS | 0.27 ± 0.006*** | 5.02 ± 0.277*** | 232.40 ± 8.72** | 215.20 ± 10.91*** | 1229.0 ± 28.29** |
| Sham | 0.28 ± 0.021*** | 4.94 ± 0.113*** | 223.33 ± 14.53* | 210.00 ± 10.00** | 1212.5 ± 31.46** |
| EXP-12 | 0.42 ± 0.003## | 3.53 ± 0.084### | 189.00 ± 14.74 | 186.00 ± 8.88* | 1022.7 ± 15.84# |
| EXP-24 | 0.49 ± 0.008### | 3.74 ± 0.174## | 159.33 ± 18.55## | 149.50 ± 7.41## | 975.7 ± 55.64## |
|
| |||||
Values are presented as mean ± SEM from 5 rats in each group. SOD; Superoxide dismutase, MDA; Malondialdehyde, AST; Aspartate transaminase, ALT; Alanine transaminase, ALP; Alkaline phosphatase, PCOS; Polycystic ovary syndrome, EXP-12; Experimental group 12, EXP-24; Experimental group 24, * ; Statistically different from the control rats, # ; Statistically different from the PCOS rats, * , # ; P≤0.05, **, ##; P≤0.01, and ***, ###; P≤0.001.